Search for information about a product,
therapeutic area or event

Media, investors, advocacy organizations and others, please contact us here.

Hero Section Background Image

Publications

Access Travere’s peer-reviewed publications.

Filter by:

Year

Year

×

Therapeutic area

Therapeutic area

×

Disease area

Disease area

×

Product

Product

×

Study/Registry

Study/Registry

×

Study type

Study type

×

Resource type

Resource type

×
Clear All

Filter by:

Year

Year

×

Therapeutic area

Therapeutic area

×

Disease area

Disease area

×

Product

Product

×

Study/Registry

Study/Registry

×

Study type

Study type

×

Resource type

Resource type

×

Results41

Sort by

Population-Level Risk Factors for Kidney Outcomes in IgA Nephropathy: The CURE-CKD Registry
Publication NephrologyIgAN

Population-Level Risk Factors for Kidney Outcomes in IgA Nephropathy: The CURE-CKD Registry

Kidney Medicine – 2025

Read more
The Humanistic Burden of Focal Segmental Glomerulosclerosis on Patients and Care‑Partners in the United States
Publication NephrologyFSGS

The Humanistic Burden of Focal Segmental Glomerulosclerosis on Patients and Care‑Partners in the United States

Quality of Life Research – 2025

Read more
Population Risk Predictors of Major Adverse Kidney Events Attributed to Focal Segmental Glomerulosclerosis from the CURE-CKD Registry
Publication NephrologyFSGS

Population Risk Predictors of Major Adverse Kidney Events Attributed to Focal Segmental Glomerulosclerosis from the CURE-CKD Registry

BMC Nephrology – 2025

Read more
Long-Term Outcomes in Nephrotic Syndrome by Kidney Biopsy Diagnosis and Proteinuria
Publication NephrologyFSGS

Long-Term Outcomes in Nephrotic Syndrome by Kidney Biopsy Diagnosis and Proteinuria

Journal of the American Society of Nephrology – 2025

Read more
Publication NephrologyIgAN

Clinical Study Outcomes in IgA Nephropathy: A Systematic Literature Review and Narrative Synthesis

2025

Read more
Load more
MSL CTA Image

Connect with our MSL team today

Arrange a meeting with a member of our medical science liaison (MSL) team to discuss the latest insights, clinical trial data, and management trends.

Find your MSL